| Goals / remit of the organisation: |
SFL Regulatory Affairs & Scientific Communication Ltd (SFL) is a multi-national team with extensive experience in the pharmaceutical as well as medtech industries.
SFL’s core competencies are:
• Regulatory Affairs
• Public Affairs
• Legal Services
• Medical Communication
This enables us to understand and meet clients’ needs through every stage of the product lifecycle. Each team member has a proven track record in specific areas of expertise and an excellent understanding of the interconnectedness of the different stages and functions of the lifecycle of a product.
Public Affairs Services
SFL advises organizations on how to engage in the EU debate to shape healthcare policies and regulatory frameworks. Our team has extensive hands-on experience and proven success in contributing to EU healthcare laws and policies. SFL's public affairs team has worked in functions inside the industry as well as in the public sector. Our public affairs services comprise:
EU political intelligence (monitoring, impact analysis of coming/changing laws and policies, news updates tailored to client needs)
Engagement strategy (stakeholder mapping, strategic partnerships, working with industry associations, step-by-step plans to address policy and regulatory matters, support with drafting communication materials, coordination of workshops and debates)
Capacity building (training on Eu institutions and legislative processes, public affairs methods and tools, lobbying codes, advice on internal organizational matters to help clients formulate aligned positions and speak with one voice to regulators and policy-makers)
The SFL team works from offices in Switzerland and the United Kingdom, Europe’s key locations for healthcare product development. We support our clients by offering personalized and comprehensive services which, when combined, provide an integrated solution for products from the bench to the marketplace within one consultancy.
SFL offers expertise in the following product classes - drugs, medical devices, in vitro diagnostics, combination products, and ATMPs - and in a broad range of therapeutic areas.
SFL is an associate member of EuropaBio and its Managing Director Shayesteh Fürst-Ladani is the Chair of EuropaBio's Topic Group on Combination Products since 2010.
|
